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Abstract 
The presence of low amounts of specific proteins in urine can be an indicator of diagnosis and prognosis 
of several diseases including renal failure and cancer. Hence, there is an urgent need for Point-of-Care (PoC) 
methods, which can quantify microproteinuria levels (30-300 ppm) and identify the major proteins associated 
with the microproteinuria. In this study, we coupled ultracentrifugation with Attenuated Total Reflectance-
Fourier Transform Infrared (ATR-FTIR) to identify and quantify proteins in urine at low ppm levels. The 
process involves the pre-concentration of proteins from 500 µL of urine using an ultrafiltration device. After 
several washings, the isolated proteins are dried onto the ATR crystal forming a thin film. Imaging studies 
showed that the absorbance of the protein bands was linear with the amount of mass deposited on the crystal. 
The methodology was first evaluated with artificial urine spiked with 30-300 ppm of albumin. The calibration 
showed acceptable linearity (R2=0.97) and a limit of detection of 6.7 ppm. Linear relationships were also 
observed from urine of healthy subjects spiked with microproteinuria concentrations of albumin, 
immunoglobulin and haemoglobin giving a prediction error of the spiked concentration of 23 ppm. When 
multiple proteins were spiked into the real urine, multivariate analysis was able to decompose the dataset into 
the different proteins, but the multicomponent evaluation was challenging for proteins at low levels.  Although 
the introduction of a pre-processing step reduces the PoC capability of the method, it largely increases its 
performance, showing great potential as a tool for the diagnosis and prognosis of several illnesses affecting 




Proteins are the major non-aqueous component of blood plasma, but in healthy patients their concentration 
in urine is minimal because they are filtered by the kidney. The presence of proteins in urine is associated with 
a wide range of conditions that can be differentiated by three ranges of concentrations, which are defined 
based on the volume of urine produced in 24 hours. Protein amounts within the normal range (< 30 mg L-1 or 
<30 mg of proteins /24 hours) are present in urine naturally. Values above 300 mg L-1 or 300 mg of 
proteins /24h indicate macroproteinuria, a condition symptomatic of several diseases, such as renal and cardiac 
conditions.1 Protein values between 30 and 300 mg L-1 or between 30 and 300 mg /24 hours are defined as 
microalbuminuria, which is also related to numerous conditions, including renal malfunction2 and cancer3.  
When microproteinuria is caused by albumin it is often referred to as “microalbuminuria”. This parameter 
is especially important as a marker of diabetes mellitus and hypertension and is used for both, prognosis and 
diagnosis.4–6 Proteic analysis of urine is an emerging tool for the study and detection of several diseases,7,8 
however, the tests are not routine and not suitable for PoC diagnosis. New methods should be quick, cost-
effective and simple to use in order to quantify proteins within the microproteinuria concentration range in 
urine (30-300 ppm based on the volume of urine produced in 24 hours). Ideally, methods should also identify 
the major proteins contained in urine to provide more diagnostic information about the cause of 
microproteinuria. In the clinical setting, regular urine dipsticks can detect protein concentrations only above 
the microporteinuria level. Microalbuminuria is evaluated using specific dipsticks such as the “Micral-Test”. 
These strips are based on immunological antibodies highly specific for human albumin and are very suitable 
for PoC testing. On the other hand, they offer semi-quantitative results and only have a limited concentration 
range (20-200 ) resulting in low specificity 9. 
Fourier Transform Infrared (FTIR) spectroscopy has shown great potential in quantifying clinical 
parameters10 and diagnosing disease11–13. Biochemical components absorb infrared light at specific 
wavelengths and the resulting spectrum can be related to the presence and concentration of biological 
molecules. FTIR spectroscopy is a versatile technique because the sample spectrum can be measured in a wide 
range of instruments, from high performance microscopes to portable spectrometers. The latter are becoming 
very popular because their suitability as PoC diagnostic tools. They can provide information about the major 
composition of the sample with minimum or no sample treatment. Attenuated Total Reflectance (ATR) is the 
preferred technique for PoC testing because it only requires depositing few microliters of the sample onto the 
ATR crystal. In urine, ATR-FTIR spectroscopy has been proposed for quantifying creatinine, urea, phosphate, 
uric acid, pH and sulphate 14,15 and cystinuria16. The determination of albumin from untreated urine has also 
been investigated using FTIR spectroscopy, proven to be successful at high macroalbuminuria levels but 
clearly ineffective at microalbuminuria levels17, showing a “significant spread especially at low concentration 
values”14. 
The main challenge in quantifying clinical parameters in urine using ATR is the lack of sensitivity. For 
example, in serum, studies indicate that the limited pathlength of ATR makes it difficult to quantify parameters 
below 20 mg/dL such as uric acid or creatinine 10,18,19. In urine, low concentrated analytes such as exogenous 
compounds have been determined only after sample pre-treatment steps, which isolated the analyte from the 
rest of urine components and enabled the pre-concentration of the target compound on the surface of the 
crystal. For example solid-phase micro-extraction (SPME) and liquid-liquid micro extraction were used to 
detect ibuprofen20 and lidocaine21 at the low ppm range, respectively.  
Recently, ultrafiltration devices have been used to separate proteins from metabolites in serum prior to 
infrared analysis.22 Reports indicate that measuring the low and high molecular fraction improved the 
determination  of glucose23 and IgG24, respectively. The aim of this study was to develop a method for the 
quantification and identification of microproteinuria by coupling ultrafiltration with ATR-FTIR for the 
quantitative measurement of dried urine films. Artificial urine was used to establish the Limit of Detection 
(LOD) and limit of quantification (LOQ) of the technique, because in all the volunteer urine analyzed there 
was some evidence of protein. This is well established in the literature, where studies on healthy volunteers 
always show low levels of protein (< 30 mg L-1 or <30 mg of proteins /24 hours).1 The methodology was then 
evaluated using urine from volunteers spiked with albumin, immunoglobulin and hemoglobin at 
microproteinuria levels. Dry films were analysed using imaging techniques to evaluate the morphology and 
investigate what areas of the dried film were best suited for quantification.  
Methods 
Samples and chemicals 
Urine was collected from healthy volunteers (N=6, ethical approval by Monash University Committee: 
2019-21431-34708). Prior to treatment, it was kept at room conditions until the temperature of the sample 
stabilized. All samples and artificial urine were filtered using 0.22 µm filters from Corning incorporated 
(Corning, USA) in order to remove cells or other impurities. Artificial urine was synthesised following the 
same protocol as in Worramongkona et al25. Standards of CaCl2, Creatinine, KCl, MgSO4, Sodium Citrate, 
NaCl, NaHCO3, Na2HPO4, NaH2PO4, Na2SO4, NH4Cl, Urea and Uric acid used for creating artificial urine 
were obtained from Merck (St. Louis, USA). The pH of the artificial urine was adjusted to 6.0 using HCl. 
Albumin and hemoglobin standards were purchased from Merck (St. Louis, USA) and immunoglobulin 
standards were purchased from Lee Biosolutions (Maryland, USA) 
Protein pre-concentration and extraction 
500 µL of spiked urine or artificial urine was transferred to a 0.5 mL Amicon© ultra-filtration device with 
a nominal molecular weight limit of 10 kDa purchased from Merck (St. Louis, USA). Samples were 
centrifuged at 14000 g for 15 minutes. Clean-up of the extract was carried out in the same device. 450 µL of 
ultrapure water was added to the pre-concentrated urine extract and the mixed solution was centrifuged at 
14000 g for 15 minutes. The washing process was repeated 3 times. Prior to the measurements, the pre-
concentration devices were washed with ultrapure water following the instructions of the manufacturer in 
order to minimize glycerol contamination. 
Dry film measurement and data treatment 
0.8 µL of the extracts were deposited on the ATR crystal using a standard 0.1-1 µL pipette. The deposited 
volume was dried under a gentle air-flow until no signal of water was found in the spectra (1-2 minutes), 
which was monitored using the O-H stretching (3200 cm-1) and bending bands (1600 cm-1) from liquid water. 
An FTIR ALPHA© spectrometer from Bruker (Ettlingen, Germany) was used to acquire the spectra. The 
instrument was equipped with a single bounce diamond ATR crystal. Spectra were measured at 4 cm-1 spectral 
resolution, co-averaging 40 interferograms (40 seconds). A background spectrum of the clean empty cell was 
acquired every hour, or immediately after observing water vapour bands, by co-adding 100 interferograms. 
Each spectrum was computed by averaging 3 depositions (120 scans in total). The spectrometer was controlled 
using OPUS software from Bruker (Ettlingen, Germany). Data analysis, including Principal Component 
Analysis (PCA) and integration of the spectral bands were carried out using in-house written functions in 
Matlab from Mathworks (Natick, USA) and the PLS toolbox from Eigenvector (Manson, USA). Before 
integration of amide I and II bands spectra were smoothed using a Savitzky–Golay filter with a 21-points 
window width over the spectral range 1507-1700 cm-1, using baselines fitted on the 1492-1503 cm-1 and 1720-
1750 cm-1 regions. Multivariate Curve Resolution- Alternate Least Squares (MCR-ALS) was carried out using 
the interface developed by Roma Tauler’s group.26 
Imaging analysis of the Dry films. 
Dry films were deposited on an ATR crystal which was detached from an instrument and placed on the 
stage of an Alpha 300 Raman confocal microscope from Witec (Ulm, Germany). This microscope was used 
for acquiring visible images using a 10x objective. Topography images were measured by employing an 
Atomic Force Microscope (AFM) nano-IR II from Anasys (Santa Barbara, USA). 
Results  
Evaluation of the pre-concentration and purification processes 
Initially we studied the composition of urine from a healthy volunteer and inevstiagted pre-concentrated 
extracts by acquiring ATR-FTIR spectra from the dried films. Figure 1a (blue spectrum) shows the spectrum 
of raw urine before sample treatment and after the pre-concentration and washing steps. The spectrum of 
untreated urine is dominated by the signals of urea and creatinine, which are the major components of urine. 























modes of urea, respectively. These peaks also overlap with νas(CN) and ẟ(NH) modes from creatinine. A visual 
inspection of the amides I and II region does not reveal any signal of proteins. In healthy urine, concentrations 
of urea and creatinine are found in the 4000-12000 ppm and 500-2000 ppm ranges, respectively (See Scheme 
S1) for a graphical comparison of metabolites and protein levels in urine). These major metabolites are three 
orders of magnitude more concentrated than proteins at microproteinuria levels (30-300 ppm), which implies 
that proteins will be diluted in the urea and creatinine film and will be hardly detectable at microproteinuria 
or lower levels, as in the case of the healthy volunteer. This is in good agreement with results from Shaw et 
al17, where the predicted vs reference figure shows that multivariate analysis was able to quantify proteins 
only above 10000 ppm  
  
 
Figure 1. (a) Typical spectra of dried films from a urine sample before treatment and after pre-concentration 
and purification steps. Sample was collected from a healthy volunteer. (b) Second derivative spectra of pre-
concentrated urine spiked with different levels of albumin (ppm). 
 
After the pre-concentration step, protein levels are multiplied by the pre-concentration factor (considering 
initial and final volumes, the pre-concentration factor was roughly 22), whereas the level of other metabolites 
remains the same. Microproteinuria pre-concentrated levels would correspond roughly to 600-6000 ppm 
(<600 ppm for the healthy volunteers). At first sight, the spectrum of the pre-concentrated urine remains 
similar to the spectrum of the raw urine and no signal of protein was found (refer to orange spectra in Figure 
1a). Bands in the range 1100-900 cm-1, which appear in the pre-concentrated urine, are assigned to alcohol 
from the glycerol and are used as preservatives in the membrane. However, in another experiment, urine was 
spiked with low levels of albumin (10-300 ppm) to investigate microproteinuria concentrations. The spectra 
of the dried film of the pre-concentrated samples are shown in Figure 1b. The second derivative revealed that 
there was a shoulder on the urea ẟ(NH) band at 1545 cm-1 directly proportional to the concentration of spiked 
albumin and proving the shoulder corresponded to the Amide II of proteins.  
These results demonstrate that ATR FTIR spectra of pre-concentrated extracts can quantify 
microproteinuria in urine. Nevertheless, two main challenges of this hypothetical method could be anticipated. 
First, since the dried film contains mainly urea, creatinine and other metabolites, the absorbance of the 1545 
cm-1 shoulder is related to the relative concentration of proteins to the other components instead of having a 
linear relationship with the real concentration in the original urine sample. Secondly, the protein signals are 
obscured by the urea bands, and it is difficult to extract information about the nature of the protein causing the 
microporteinuria. Hence, a washing procedure was introduced. When 450 µL of ultrapure water was added to 
the pre-concentrated extract, the metabolites and proteins were diluted 22 times. After ultracentrifugation, the 
proteins were again pre-concentrated but the non-proteic molecules remained diluted. Thus, the resulting 
extract contained 22 times more proteins and 22 times less non-proteic interferences (e.g. urea, creatinine and 
sulphates). If this process is repeated 3 times, the molecules, which are not retained in the filter, are diluted 
more than 10000 times (see Scheme S1). Figure 1a shows the resulting spectra that display typical features of 
isolated proteins. Amide A (3303 cm-1), I (1640 cm-1), II (1542 cm-1) and III (1388 cm-1) bands dominate the 
spectra, indicating proteins of the healthy volunteers were being detected. The intense band in the alcohol 
region (1200-100 cm-1) is not a typical band from proteins and may be caused by the presence of glycerol 
remnants or glycoproteins, e.g. transferrin. 
LOD, LOQ and reproducibility studies on artificial urine 
The fact that it is possible to measure a clear spectrum of isolated proteins in urine from a healthy 
volunteer led to the development of a method for detecting and quantifying microporteinuria. From the outset, 
it was necessary to determine a reproducible relationship (ideally linear) between the protein concentration 
and the protein bands from the dried film spectra. Given all the urine samples form volunteers contained 
proteins, it was difficult to establish proper blanks to calculate analytical figures of merit such as the LOD. 
Thus, artificial urine spiked with albumin was used. Figure 2 shows the spectra at artificial urine spiked with 
different levels of albumin within the microproteinuria range. It can be clearly seen that the amide bands 
increase as the concentration of protein increases. We also studied the effect of the ATR correction on the 
calibration, but the corrected spectra (Figure S1) provided similar results. The integration of the amide bands 
(1700-1500 cm-1, using baselines fitted on the 1503-1474 cm-1 and 1750-1720 cm-1 regions) were used for 
computing a univariate calibration (see Figure 2b). The integrated area was found to be linear with the spiked 
concentration in the microalbuminuria range of concentrations (R2=0.97). The LOD, calculated as the 
concentration corresponding to three times the standard deviation of the blanks was found to be 6.7 p.p.m. 
(LOQ 22 ppm). The blanks used were pre-concentrated extracts of artificial urine without spiking, and a visual 
inspection of the spectra revealed contaminations of glycerol and other components (See Figure S2). Although 
the intensities are negligible compared with microporteinuria concentration levels, the presence of these bands 
increased the standard deviation of the blank signals and raised the LOD. For the control blanks, distilled 
water was dried onto an ATR crystal and the LOD was calculated to be 1 ppm. Hence, glycerol contamination 
is affecting the sensitivity of the method and there is still room for improvement for achieving lower detection 
limits. Nevertheless, the calculated LOQ is below the lower critical value for microproteinuria diagnosis (20 
ppm). Regarding reproducibility, Relative Standard Deviation (RSD%) values of 8.5, 8.1, 6.9, 6.2 and 14%, 
were found for the 20, 50, 100, 200 and 200 ppm solutions, respectively. These values refer to three replicates 
of each measurement and on three calibrations obtained on different days (n=9). 
  
Figure 2. (a) Average spectra of proteic extracts from artificial urine spiked with different amounts of albumin 
within the microalbuminuria range. (b) Calibration obtained using the integrated area under the Amide I and 
II bands. Error bars indicates confidence intervals for a significance level of 0.05 (n=9). 
 
 





















The linearity of the absorbance with the concentration found in the previous section raised a question 
about the morphology of the dried films. According to the Beer-Lambert Law, absorbance of an analyte is 
(approximately28) directly proportional with the concentration of the specific compound and the pathlength. 
The spectra in Figure 2 indicate that dried films are almost entirely composed of proteins, so the concentration 
of proteins can be considered as constant. This is a very different scenario from previous work on dried films 
measured in transmission, where the concentration of dried films is variable and internal standards such as 
KSCN are used to compensate for changes in the pathlength 29,30. In our study, the linearity of the signal with 
the concentration of the solution observed in Figure 2 can only be caused by changes in the pathlength. This 
can be explained if we consider that, as long as the volume deposited is constant, the amount of proteins 
deposited on the ATR crystal is proportional to the concentration of proteins in solution. Considering a 0.8 µL 
deposit of protein, concentrations of 20, 50, 100, 200 and 300 ppm (mg L-1) will lead to depositions of 16, 40, 
80, 160 and 240 pg. The method can only be linear if this increase of mass involves a proportional change in 
the pathlength, i.e. the dried film occupies more of the active volume of the sensor. Considering the complex 
behaviour of the evanescent wave in an ATR crystal, the linearity will depend on the morphology and 
reproducibility of the dried film created. As this is of critical concern for the proposed method, we performed 
an investigation into dried films using imaging techniques. 
Figures 3a and 3b show spectra of urine from a healthy volunteer spiked with 50, 150, 300, 500, 600, 800, 
1000 ppm of albumin. The integrated area of the amide I and II bands increased linearly in the lower and 
medium concentration range. Above 600 ppm the sensitivity starts to decrease indicating saturation. Dry films 
from the calibration solutions were studied using a visible microscope. Figure 3c shows the visible images of 
the dry films obtained from drying the extracts of the spiked urine on an ATR diamond crystal.  It can be seen 
that the dried film has a ring shape, and the metallic boundaries fixing the ATR crystal confined the droplet 
on the crystal, ensuring that the evanescent beam interrogated the whole of the deposited mass. The ring is 
caused by the so-called coffee ring effect, which has been previously described31. This is depicted in the Figure 
3d, which shows a graphical representation of the drop on the dried surface of the ATR crystal. Figure 3c 
indicates that in the range between 50 and 500 ppm, as the spiked concentration of albumin is increased, the 
amount of proteins observable on the centre of the ring increased. After 500 ppm, the centre of the ring is 
completely covered by proteins. The fact that this concentration point roughly corresponds to the saturation 
of the signal (Figure 3a) suggests that the absorbance increases on increasing the amount of proteins in  the 
centre of the ring, and it saturates once all the ring is covered. 
Dry films reported in previous serum studies from Hughes et al32,33 showed a different shape, containing 
much more proportion of the absorbance in the middle of the ring. For example, the deposition of 1µL of the 
10-100 KDa fraction of serum resulted in a homogenous thick film being formed,  as opposed to a ring. The 
singular shape of the urine dried films appears to be the result of the low concentration of proteins in the pre-




Figure 3. Study of dried films. (a) Calibration curve of urine spiked with albumin (Amide I and II bands). 
Error bars represent the confidence interval for a significance level of 0.05. (b) Average spectra of the 4 
replicate spectra of dried films measured by ATR-FTIR spectroscopy. (c) Visible images of the dry films on 
an ATR crystal obtained from the extracts of urine spiked at different concentrations (d) Diagram showing 
the drying process (e) and (f) AFM topographical images of the rings formed by extracts of artificial urine 
spiked with 0 and 50 ppm, respectively. Profiles are available in Figure S3. (g) AFM image of the middle of 
the ring of the dried film created after dried in a 1000 ppm albumin solution. 
AFM was used to study the thickness of the ring. As it was impossible to place the plate of the ATR under 
the AFM stage, this study was performed on CaF2 substrate. The penetration depth of the evanescent field 
through a diamond ATR crystal at 45 degrees and a refractive index of 1.5 for the dry film, ranges from 0.5 
to 5 microns in the 4000-400 cm-1 range. In the amide I and II region (1800-1400 cm-1), where the calibrations 
were performed between 1-1.3 µm (Calculated using equation available on Figure S1). For a blank of artificial 
urine, the thickness of the dried film was already above 1 m (See figure 3d). For low concentrations such as 
50 ppm, the thickness was above 2 µm (Figure 3e) and rings from dried films of 100 and 150 ppm also had a 
thickness above this 2 µm. AFM profiles are available in Figure S3. Thus the contribution of the height to the 
spectra should be the same for all concentrations above 50 ppm and thus, the linearity cannot be given by the 
ring thickness. AFM images from the central region of the dried films corresponding to low concentrated 
solutions revealed that there are small depositions of proteins with a thickness below the penetration depth of 
the ATR (See Figure 3g). This is consistent with the AFM images for 50-150 ppm in Figure 3a. providing 
evidence that the amount and distribution of these small depositions could explain the linearity. It should be 
noted that this AFM analysis was performed on a CaF2 substrate, and the drying of the extracts can present 
differences to the dry rings obtained on diamond. 
In summary, the data suggested that the linearity between the absorbance and the protein concentration 
observed empirically could be caused by an increase in the surface area of the ATR crystal covered by the 
protein deposit. We conclude that further studies are needed to understand more about the morphology of the 
dried film, which will help to create optimised films, which homogeneously distribute the proteins on the ATR 
crystal, increasing sensitivity and selectivity. 
Spiking of human urine samples 
Artificial urine does not contain all of the components and cell types found in human urine and hence the 
method was further evaluated using urine samples from 6 healthy volunteers spiked with albumin, 
haemoglobin and immunoglobulin, at microproteinuria levels. Values of the integrated areas of the amide I 
and II bands plotted against the spiked concentration are shown in Figure 4. It can be seen that the absorbance 
was linear with the spiked concentration in the microproteinuria range. The spectral bands from proteins were 
detected in all urine from the healthy volunteers, indicating that the method had enough sensitivity to detect 
proteins in urine from healthy individuals. A simultaneous calibration model using artificial urine was created 
in parallel for each calibration, which was used to calculate the protein concentration in each solution. For 
evaluating the accuracy of the method, the estimated spiked concentrations were calculated by computing the 
concentration of the solution and then subtracting the estimated concentration of the corresponding un-spiked 
urine. A comparison of the estimated values and the spiked values (See Figure S4) was used to compute the 
RMSEP, which was found to be 23 ppm   
 
Figure 4. Calibration curves for the 6 different urine samples spiked with albumin, haemoglobin or 
immunoglobulin at different concentrations. The integrated value refers to the area under the Amide I and II 
bands. 
 
Identification of the proteins causing the microproteinuria 
Each protein shows different spectral patterns caused by differences in both the protein secondary 
structure and the amino acid composition.34,35 These specific spectral patterns can be exploited by multivariate 
analysis to develop classification models, which can distinguish the protein causing the microproteinuria.  In 
a simple scenario where microproteinuria is caused by a single protein (i.e. the other proteins remain below 
the normal cut-off), multivariate analysis could use the specific spectral features of proteins to detect the 
protein causing the microproteinuria. The dataset from the previous section from healthy urine spiked with 
different amounts of hemoglobin, albumin and immunoglobulin was used to identify the specific protein 
spiked into the urine. To correct for confounding effects such as the concentration, spectra were normalized 
using SNV. The PCA scores plot (Figure 5a) showed that the spectra were clustered according to the specific 





A more complex problem is the detection of different proteins when they are above the microproteinuria 
level. The extracted spectra will be a combination of contributions from the different major proteins, and 
multivariate analysis needs to decompose the spectra among their different constituents. To test this scenario, 
a co-spiking experiment was carried out combining spiking 18 aliquots from a volunteer urine sample with 0, 
50, 150 and 300 ppm of albumin and immunoglobulin and 0 and 50 ppm of haemoglobin (See Table S1). The 
haemoglobin was kept to lower levels to investigate minor contributors to the spectra. 
MCR-ALS analysis was applied to this dataset using non negativity constraints in both, concentrations 
and spectra. Singular Value Decomposition (SVD) indicated 4 components. Figure 5a compares the pure 
spectra of the first three components extracted by MCR-ALS while the fourth component, shown in Figure 
S5, represented non proteic urine components) with standard spectra of the proteins assigned. It can be seen 
that spectral profiles are similar to the standard spectra, with correlation coefficient values of 0.9, 0.97 and 
0.97 for immunoglobulin, hemoglobin and albumin, respectively. Concentration profiles (See Figure S6) 
indicated a clear correlation between the concentration spiked of albumin and immunoglobulin and the relative 
concentration extracted by the MCR-ALS. Nevertheless, for hemoglobin the method was not able to 
discriminate between the 0 and 50 ppm, indicating that the multi-quantification of several proteins can be 
problematic at low concentration levels. A deeper study of the multicomponent prediction of proteins is out 
of the scope of this study but future studies on human urine will improve the robustness of the modelling. 




Figure 5. (a) Scores plot showing the clustering of spectra according to the type of protein that was spiked 
into the urine. Each point represents the spectrum of a urine sample spiked with albumin, haemoglobin or 





The results show that the combination of ultrafiltration and ATR-FTIR spectroscopy of dried films 
provides a method for the quantification of proteins in the microproteinuria range. The pre-concentration and 
washing steps isolate the proteins from other major components in urine. This enables the deposition of highly 
pure proteins onto the ATR crystal. These proteins can be quantified because the absorbance of the proteins 
is linear with the concentration of proteins in the solution. Images indicated that the dried films form a ring 
instead of a thin homogeneous film. The linearity of Amide I and II band absorbance with protein 






















concentration in the deposited solution is caused by the amount of mass deposited on the crystal being directly 
proportional to the concentration of proteins in the original solution. In addition, the differences in the ATR-
FTIR spectra of each protein provided information on the type of protein spiked into the urine. The 
identification of a single protein causing microalbuminuria was straight forward, but the multicomponent 
detection and quantification of several proteins was challenging for low levels of microalbuminuria.  
Nevertheless, there are more challenges to be solved before the translation of the methodology to the 
clinic. The sample preparation step can be simplified by reducing the number of washing steps, which can be 
achieved  using ultracentrifugation devices with a larger volume. The reproducibility of the deposition can be 
also improved by using an automated micro-dispenser. Although, the aim of this paper is to present and discuss 
the analytical capabilities of the method, the next step is to evaluate it under clinical conditions, and we are 
currently proceeding with a clinical study using urine from diabetic patients. The proposed method shows vast 
potential in the diagnosis and prognosis of several illnesses, which affect the protein composition of urine, 
and may provide a  versatile tool for the quantification and identification of microporteinuria in the future.  
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Additional information about the composition of Urine, ATR correction, blanks, dry film topography, co-
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